Lasioglossin LL-II
Need Assistance?
  • US & Canada:
    +
  • UK: +

Lasioglossin LL-II

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Lasioglossin LL-II is an antibacterial peptide isolated from Lasioglossum laticeps (Eusocial Bee). It has activity against gram-positive bacteria, gram-negative bacteria and cancer.

Category
Functional Peptides
Catalog number
BAT-012587
Molecular Formula
C84H149N23O16
Molecular Weight
1737.2
IUPAC Name
(2S)-N-[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S,3S)-1-[[(2S)-1-[[2-[[(2S)-6-amino-1-[[(2S,3S)-1-[[(2S,3S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-amino-3-methylbutanoyl]amino]butanediamide
Synonyms
Lasioglossin II; H-Val-Asn-Trp-Lys-Lys-Ile-Leu-Gly-Lys-Ile-Ile-Lys-Val-Ala-Lys-NH2
Purity
98.0%
Sequence
VNWKKILGKIIKVAK-NH2
Storage
Store at -20°C
InChI
InChI=1S/C84H149N23O16/c1-14-49(10)68(105-77(116)59(34-22-27-39-88)98-74(113)58(33-21-26-38-87)99-78(117)62(42-53-44-93-55-30-18-17-29-54(53)55)101-79(118)63(43-64(90)108)102-80(119)66(91)47(6)7)83(122)103-61(41-46(4)5)73(112)94-45-65(109)96-57(32-20-25-37-86)75(114)106-70(51(12)16-3)84(123)107-69(50(11)15-2)82(121)100-60(35-23-28-40-89)76(115)104-67(48(8)9)81(120)95-52(13)72(111)97-56(71(92)110)31-19-24-36-85/h17-18,29-30,44,46-52,56-63,66-70,93H,14-16,19-28,31-43,45,85-89,91H2,1-13H3,(H2,90,108)(H2,92,110)(H,94,112)(H,95,120)(H,96,109)(H,97,111)(H,98,113)(H,99,117)(H,100,121)(H,101,118)(H,102,119)(H,103,122)(H,104,115)(H,105,116)(H,106,114)(H,107,123)/t49-,50-,51-,52-,56-,57-,58-,59-,60-,61-,62-,63-,66-,67-,68-,69-,70-/m0/s1
InChI Key
XNOLUCFBUPSLEH-RDWPUYCTSA-N
Canonical SMILES
CCC(C)C(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)N
1. Model membrane interaction and DNA-binding of antimicrobial peptide Lasioglossin II derived from bee venom
Susmita Bandyopadhyay, Meryl Lee, J Sivaraman, Chiradip Chatterjee Biochem Biophys Res Commun. 2013 Jan 4;430(1):1-6. doi: 10.1016/j.bbrc.2012.11.015. Epub 2012 Nov 14.
Lasioglossins, a new family of antimicrobial peptide, have been shown to have strong antimicrobial activity with low haemo-lytic and mast cell degranulation activity, and exhibit cytotoxic activity against various cancer cells in vitro. In order to understand the active conformation of these pentadecapeptides in membranes, we have studied the interaction of Lasioglossin II (LL-II), one of the members of Lasioglossins family with membrane mimetic micelle Dodecylphosphocholine (DPC) by fluorescence, Circular Dichroism (CD) and two dimensional (2D) (1)H NMR spectroscopy. Fluorescence experiments provide evidence of interaction of the N-terminal tryptophan residue of LL-II with the hydrophobic core of DPC micelle. CD results show an extended chain conformation of LL-II in water which is converted to a partial helical conformation in the presence of DPC micelle. Moreover we have determined the first three-dimensional NMR structure of LL-II bound to DPC micelle with rmsd of 0.36Å. The solution structure of LL-II shows hydrophobic and hydrophilic core formation in peptide pointing towards different direction in the presence of DPC. This amphipathic structure may allow this peptide to penetrate deeply into the interfacial region of negatively charged membranes and leading to local membrane destabilization. Further we have elucidated the DNA binding ability of LL-II by agarose gel retardation and fluorescence quenching experiments.
2. Lasioglossins: three novel antimicrobial peptides from the venom of the eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae)
Václav Cerovský, et al. Chembiochem. 2009 Aug 17;10(12):2089-99. doi: 10.1002/cbic.200900133.
Three novel structurally related pentadecapeptides, named lasioglossins, were isolated from the venom of the eusocial bee Lasioglossum laticeps. Their primary sequences were established as H-Val-Asn-Trp-Lys-Lys-Val-Leu-Gly-Lys-Ile-Ile-Lys-Val-Ala-Lys-NH(2) (LL-I), H-Val-Asn-Trp-Lys-Lys-Ile-Leu-Gly-Lys-Ile-Ile-Lys-Val-Ala-Lys-NH(2) (LL-II) and H-Val-Asn-Trp-Lys-Lys-Ile-Leu-Gly-Lys-Ile-Ile-Lys-Val-Val-Lys-NH(2) (LL-III). These lasioglossins exhibited potent antimicrobial activity against both Gram-positive and Gram-negative bacteria, low haemolytic and mast cell degranulation activity, and a potency to kill various cancer cells in vitro. The lasioglossin CD spectra were measured in the presence of trifluoroethanol and sodium dodecyl sulfate solution and indicated a high degree of alpha-helical conformation. NMR spectroscopy, which was carried out in trifluoroethanol/water confirmed a curved alpha-helical conformation with a concave hydrophobic and convex hydrophilic side. To understand the role of this bend on biological activity, we studied lasioglossin analogues in which the Gly in the centre of the molecule was replaced by other amino acid residues (Ala, Lys, Pro). The importance of the N-terminal part of the molecule to the antimicrobial activity was revealed through truncation of five residues from both the N and C termini of the LL-III peptide. C-terminal deamidation of LL-III resulted in a drop in antimicrobial activity, but esterification of the C terminus had no effect. Molecular modelling of LL-III and the observed NOE contacts indicated the possible formation of a bifurcated H-bond between hydrogen from the Lys15 CONH peptide bond and one H of the C-terminal CONH(2) to the Ile11 oxygen atom. Such interactions cannot form with C-terminal esterification.
Online Inquiry
Verification code
Inquiry Basket